Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Abbott

Johnson & Johnson Poised To Lead Multiple Cardiovascular Markets With Shockwave Medical Acquisition

J&J’s acquisition of IVL device maker Shockwave Medical for $13.1bn sets J&J’s medtech arm solidly in a leadership position in multiple cardiovascular markets.

M & A Financing

News We're Watching: Abbott, Click, Otsuka, Prenosis Win FDA Approval; EU Health Data Space Proposal, And More

This week, Abbott, Click and Otsuka, Prenosis won the FDA nod respectively for an in vitro diagnostic to evaluate patients for concussion, the first prescription digital therapeutic to treat major depressive disorder and a software to predict sepsis. Also on the regulatory front, the FDA will now take 513(g)s forms via its eSTAR framework. In Europe, the debate of what personal information can be shared continues. 

News We're Watching Approvals

Abbott Wins FDA Approval For TriClip Repair System, Compete Against Edwards

Abbott wins FDA approval for TriClip regurgitation therapy, which will compete against Edwards Lifesciences’ recently approved Evoque transcatheter tricuspid valve replacement device. Two analysts expect Tricuspid will be eligible for a new technology add-on payment, which will be positive for Abbott.

Approvals Cardiovascular

Medtech’s Leading Revenue Earners In 2023: Johnson & Johnson Tops $30bn

Abbott’s weaker rapid diagnostic sales see the erstwhile industry leader slip down the global 2023 medtech rankings, while Johnson & Johnson passes it on the way up on the back of strong external and internal growth.

Sales & Earnings Growth
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Implantable Devices
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • Abbott Diabetes Care, Inc.
    • Abbott Laboratories
    • Abbott Medical Optics
    • Advanced Medical Optics, Inc.
    • AMO Manufacturing USA, LLC
    • Advanced Neuromodulation Systems
    • AGA Medical Corporation
    • Alere, Inc.
    • Axis-Shield plc
    • Binax, Inc.
    • Biosite, Inc.
    • CardioMEMS
    • Cephea Valve Technologies
    • CFR Pharmaceuticals S.A.
    • Cholestech Corporation
    • Domestic Formulations
    • Endocardial Solutions, Inc.
    • Endosense SA
    • EP Medsystems
    • Epicor Medical, Inc.
    • Evalve Inc.
    • Facet Biotech Corporation
    • Fournier Pharma
    • Free & Clear, Inc.
    • Garden Hills
    • Guidant Corporation Vascular Device Division
    • Ibis Biosciences
    • IDEV Technologies
    • Innogenetics nv
    • Inverness Medical Innovations Inc.
    • Irvine Biomedical
    • Kos Pharmaceuticals, Inc.
    • MediGuide Inc.
    • MediSense
    • Nanostim
    • Inc.
    • Neuromed Inc.
    • NeuroTherm Inc
    • Northstar Neuroscience, Inc.
    • OptiMedica Corporation
    • Ostex International Inc.
    • Pacesetter
    • Piramal Healthcare Solutions
    • Quest Medical, Inc.
    • Radi Medical Systems AB
    • Spinal Modulation, Inc.
    • Solvay Pharmaceuticals, Inc. (Unimed Pharmaceuticals, Inc.)
    • Spinal Concepts
    • St. Jude Medical, Inc.
    • Tendyne Holdings, Inc.
    • TheraSense, Inc.
    • Thoratec Corporation
    • Topera, Inc.
    • US Diagnostics (USD)
    • Velocimed, Inc.
    • Ventritex
    • Veropharm
    • Walk Vascular, LLC
UsernamePublicRestriction

Register